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Coproantigen ELISATriclabendazole (TCBZ) is the drug of choice for Fasciola hepatica control and reports of F. hepatica resis-
tant to this drug from a wide range of geographic regions are very concerning. This study investigated the
presence of TCBZ resistance in F. hepatica in naturally infected Australian beef and dairy cattle herds and
evaluated methods of measuring the levels of resistance. Faecal egg count and coproantigen reduction
tests (FECRT and CRT, respectively) were conducted on 6 South-eastern Australian beef properties and
one dairy property where treatment failure by triclabendazole (TCBZ) was suspected. The CRT was con-
ducted on an additional beef property. On each property 15 animals were treated with an oral prepara-
tion of TCBZ at the recommended dose and 15 animals remained as untreated controls. Fluke eggs in
faeces were counted and coproantigen levels were measured before treatment and 21 days after treat-
ment and in the untreated control animals. These data were evaluated using three different methods
to calculate % reductions compared with controls. Resistance (<90% reduction) was detected on the dairy
property using both FEC and CRT, and on 3/6 beef properties using FECRT and 4/7 beef properties using
CRT. Using the FECRT, reductions of 6.1–14.1% were observed in dairy cattle and 25.9–65.5% in beef cattle.
Using the CRT, reductions of 0.4–7.6% were observed in dairy cattle and 27.0–69.5% in beef cattle. Live
ﬂukes were recovered at slaughter following TCBZ treatment of 6 cattle from 3 of the beef properties,
conﬁrming the TCBZ resistance status of F. hepatica in these cattle. This is the ﬁrst report of F. hepatica
resistant to TCBZ in cattle in Australia and the results suggest that resistance is widespread in the
South-eastern region. The CRT is shown to be a robust alternative to the FECRT for evaluation of TCBZ
resistance in F. hepatica in cattle.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction (MLA, 2005), especially along watercourses and in irrigation zones.In Australia, livestock production losses attributed to the com-
mon liver ﬂuke Fasciola hepatica were estimated to be A$50 to 80
million per annum in 1999 and annual ﬂuke treatment alone costs
A$10 million (Boray, 2007). Over 6 million cattle graze at-risk pas-
tures with most stock concentrated in South-eastern Australia
where there is a suitable habitat for the intermediate snail hostThe epidemiology of fasciolosis is similar to other countries.
Due to its efﬁcacy against both immature and mature adult
stages of F. hepatica within the mammalian host, triclabendazole
(TCBZ) has been the drug of choice for parasite control. The emer-
gence of resistance to TCBZ now threatens ﬂuke control in livestock
in several parts of Europe (Fairweather, 2009). TCBZ-resistant
F. hepatica were ﬁrst reported from sheep in Victoria, Australia,
in 1995 (Overend and Bowen, 1995) and resistance has now been
reported in several countries both in sheep (Mitchell et al., 1998;
Moll et al., 2000; Thomas et al., 2000; Gaasenbeek et al., 2001;
Mooney et al., 2009; Sargison and Scott, 2011; Gordon et al.,
2012), and cattle (Moll et al., 2000; Olaechea et al., 2011; Ortiz
et al., 2013). Recently, a case of TCBZ-resistant F. hepatica was
reported in a human from the Netherlands. The patient did not re-
spond despite several treatments with the drug, highlighting the
serious zoonotic threat posed by fasciolosis especially that of resis-
tant parasites (Winkelhagen et al., 2012).
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tected by the use of parasite faecal egg count reduction tests (FEC-
RT). Although FECRT have not been validated for ﬂuke (Coles et al.,
2006), this method has been applied to evaluate treatment failure
and indicate the existence of possible drug resistance in F. hepatica
populations. A commercial coproantigen ELISA is available for the
detection of F. hepatica infection in ruminant livestock (Mezo
et al., 2004). Trials using sheep (Flanagan et al., 2011a,b; Gordon
et al., 2012; Novobilsky et al., 2012) and cattle (Brockwell et al.,
2013) show that this coproantigen ELISA can be used to demon-
strate survival of ﬂuke following treatment and thus in identifying
resistant populations. The recent work of Brockwell et al. (2013)
has demonstrated that this test reﬂects ﬂuke burdens in cattle
and that coproantigen levels fall within 7 days after successful
treatment suggesting that this test has utility as a method for mea-
suring reductions due to treatment. This opens the way for a copro-
antigen reduction test (CRT) to be used for measuring the level of
TCBZ resistance in F. hepatica in cattle.
In this study, we aimed to identify, for the ﬁrst time, resistant
ﬂuke isolates in cattle in Australia and to evaluate and compare
the FECRT and CRT as methods for measuring the level of drug
resistance in F. hepatica. We used the same coproantigen ELISA test
as used by others (Flanagan et al., 2011a,b; Gordon et al., 2012;
Novobilsky et al., 2012) and compared the three methods de-
scribed by Pook et al. (2002) for assessing reductions in FEC and
coproantigen ELISA values. We show that the RESO technique,
which compares post-treatment arithmetic means of treated and
control groups, was favoured because its derivation generates less
statistical error, relies on post treatment results only and is cheap-
er for ﬁeld application.2. Materials and methods
2.1. Tests
2.1.1. FEC
Pre and post treatment F. hepatica faecal egg counts (FEC) were
performed by Para-Site Diagnostic Service, Benalla, Victoria on
fresh faeces sent by overnight courier, using the Sedimentation test
for Liver Fluke, Western Australia Department of Agriculture and
Food (WADAF). The procedure was to homogenize 10 g of faeces
with 100 mL of water and pour the slurry through a sieve stack
with sequentially smaller aperture sizes (150, 90 and 45 lm).
The homogenate was washed through the sieves with a stream
of tap water followed by washing of each of the lower two sieves
after removing the sieve above. The ﬁltrate collected on the
45 lm sieve was washed into a graduated ﬂask and diluted to
100 mL with water and allowed to settle for 6 min. The superna-
tant was reduced to 20 mL using a vacuum pump, diluted again
to 100 mL with water and allowed to settle for 6 min. The sediment
was suspended in 10 mL and one drop of methylene blue
added. After 5 min, the material was transferred to a viewing
chamber and eggs counted under an inverted microscope using
40 magniﬁcation.2.1.2. Coproantigen test
To measure faecal antigen levels, aliquots of 2 g of the same fae-
cal samples were stored at 20 C for up to 3 days, and for several
months in the case of the Nimmitabel samples, until analysis with
a commercial ELISA kit for the detection of F. hepatica faecal anti-
gen (BIO K 201, BIO-X Diagnostics, Belgium). The protocol was
optimised for use in our laboratory as described (Brockwell et al.,
2013). Coproantigen values are expressed as a percentage of the
positive control antigen and corrected to allow for a zero value
by subtracting the negative cut-off value of 1.3%. This negativecut-off value was determined by the mean plus 3 times the stan-
dard deviation taken from 103 FEC negative ﬁeld samples. The
speciﬁcity of the coproantigen ELISA has been established in sev-
eral studies against natural infections of gastrointestinal nema-
todes, Moniezia, Dicrocoelium and Echinococcus (Mezo et al., 2004)
and Paramphistomum cervi (Kajugu et al., 2012; Brockwell et al.,
2013).
2.2. On-farm trials
This research was conducted with approval by Charles Sturt
University’s Animal Care and Ethics Committee. The beef cattle
properties were selected for preliminary screening following re-
ports of suspicion of treatment failure by veterinarians in the
Livestock Health and Pest Authority (NSW) and the Department
of Primary Industries (Victoria). The dairy property was selected
on the advice of a local veterinarian. The properties identiﬁed in
this trial were located at Parrots Nest, Irvington and Caniaba in
North-eastern NSW; at Numbugga, near Bega in the far South-
eastern area of NSW; Nimmitabel in the Monaro region of
South-eastern NSW; Gireke near Berrigan in the southern Riverina
irrigation area of NSW; and in the Tallangatta Valley region of
North-eastern Victoria. The dairy property was located near Maf-
fra in the Gippsland region of eastern Victoria (see Fig. 1). The
brief history of ﬂuke control on these properties is as follows.
All properties surveyed had been using TCBZ exclusively for long-
er than 5 years and treated animals orally. Only the Caniaba prop-
erty indicated that cattle were treated using a pour on as well.
None indicated using what could be considered excessive treat-
ments (>3 treatments per year). Most treated cattle once annually,
with only the Numbugga property manager stating he treated
when he thought the animals showed evidence of disease. Nim-
mitabel reported no treatment of cattle but twice yearly oral
treatment of sheep co-grazing with cattle. Parrots Nest and Irving-
ton reported 2–3 treatments per year. Scales to weigh animals
were used only on the Numbugga and Tallangatta Valley proper-
ties with all animals dosed at the rate applicable for the heaviest
weight obtained. On all other properties the animal’s weight was
estimated for dose calculation.
On each property 30 animals of no speciﬁc age or gender were
enrolled in the trial. Animals were randomly allocated to either a
treatment or control group (n = 15/group). The mean body weights
(kg ± SD) of the control and treated animals, respectively, on each
property were: Parrots Nest: 396 ± 34; 444 ± 23; Irvington: 435 ±
31; 387 ± 32; Caniaba: 552 ± 18; 502 ± 13; Nimmitabel: 314 ± 8;
298 ± 9; Numbugga: 375 ± 9; 375. ± 11; Gireke: 447 ± 15;
421 ± 19; Tallangatta Valley: 252. ± 7; 242 ± 4; Maffra: 211 ± 6;
200 ± 5. Fifteen treated cattle were dosed orally with a commercial
TCBZ drench (Flukare C, Virbac Animal Health) at the manufac-
turer’s recommended dose rates (12 mg/kg based on individual
body weight) using a drenching hook. A second group of 15 ani-
mals remained untreated as controls. Per rectum faecal collection
for FEC and coproantigen ELISA were performed on each animal
prior to treatment and 21 days post-treatment. The exceptions to
this protocol were: (i) for the Nimmitabel property poor weather
delayed the post-treatment sample collection until day 24; (ii) on
the Maffra property the ‘untreated control’ group were subse-
quently treated on day 21 and then retested for coproantigen on
day 42. There was no untreated control group for comparison with
this treated group. On some properties only 13 or 14 animals were
available on the day of testing as shown in Tables 1 and 2.
2.3. Statistical analysis
Anthelmintic resistance was declared when the calculated TCBZ
efﬁcacy was <90% (APVMA, 2001). FEC were determined as
Fig. 1. Map of South-eastern Australia showing location of properties involved in Fasciola hepatica resistance studies. Red: beef properties; blue: dairy property. Map data
2013 Google. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 1
Faecal egg count reduction test: FECRT. Faecal egg count (FEC = eggs per 10 g faeces) data from 6 South-eastern Australian beef cattle properties and one dairy property at Maffra
which was tested twice: ⁄Maffra is data from the second test. FEC Untreated controls: Initial: FEC in untreated control cattle on day of treatment; Final: FEC in untreated control
cattle on days 21–24 following treatment. Those properties identiﬁed as having TCBZ-resistant ﬂukes (reduction in FEC <90%) are indicated in bold red type; na = not applicable.
See text for explanation of methods. Method 1 = Coles et al. (1992); Method 2 = Pook et al. (2002); Method 3 = Dash et al. (1988).
LOCATION n FEC
Untreated 
controls:
Initial 
FEC
Untreated 
controls:
Final
FEC
pre-
treatment
FEC 
post-
treatment
FECRT (%)
Method 
1
Method 
2
Method 
3
Parrots Nest (NSW) 14 74 ± 28 76 ± 39 50 ± 23 5 ± 5 93.4 48.6 90.3
Irvington (NSW) 15 47 ± 26 61 ± 34 42 ± 16 1 ± 1 99.9 63.1 99.9
Caniaba (NSW) 13 292 ± 83 248 ± 63 187 ± 55 2 ± 1 99.1 96.6 98.6
Numbugga (NSW) 15 28 ± 9 55 ± 13 48 ± 10 11 ± 2 88.4 69.5 88.3
Gireke (NSW) 15 33 ± 8 33 ± 8 28 ± 8 26 ± 9 19.9 29.7 12.9
Tallangatta Valley (Vic) 15 36 ± 11 76 ± 18 27 ± 6 16 ± 4 78.9 27.0 72.2
Maffra (Vic) 11 27 ± 14 28 ± 9 39 ± 38 23 ± 23 18.7 0.4 43.6
*Maffra (Vic) 14 na na 28 ± 9 31 ± 10 na 7.6 na
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with TCBZ. Reductions in faecal egg count (FECR) and in coproanti-
gen levels (CR) were calculated using the Excel procedure triFECTAversion 4 (Charles Sturt University) designed originally for FECR.
Results are obtained using 3 methods described by Pook et al.
(2002): Method 1 is the RESO technique as recommended by the
Table 2
Coproantigen reduction test: CRT. Coproantigen levels (Background corrected and presented as % positive of control wells) from 7 South-eastern Australian beef cattle properties
and one dairy property at Maffra which was tested twice: ⁄Maffra is data from the second test. FEC Untreated controls: Initial: FEC in untreated control cattle on day of treatment;
Final: FEC in untreated control cattle on days 21–24 following treatment. Those properties identiﬁed as having TCBZ-resistant ﬂukes (reduction in % positive control
antigen < 90%) are indicated in bold red type, na = not applicable. Methods as in Table 1.
LOCATION n
Untreated 
controls:
Initial 
Untreated 
controls:
Final
% positive
pre-treatment
% positive 
post-
treatment
CRT(%)
Method 
1
Method 
2
Method 
3
Parrots Nest (NSW) 14 20 ± 5.9 19 ± 5.8 11.3 ± 3.3 0.0 ±  0.0 100 65.5 100
Irvington (NSW) 15 13.2 ± 5.1 19.5 ± 6.8 12.7 ± 4.7 0.0 ±  0.0 100 55.2 100
Caniaba (NSW) 13 67.4 ± 8.0 71.7 ± 8.5 64.4  ±  9.0 0.2 ± 0.2 99.8 98.4 99.8
Nimmitabel (NSW) 15 12.8 ± 4.1 27.1 ± 7.4 11.5 ± 4.2 2.7 ± 1.3 89.9 52.1 88.7
Numbugga (NSW) 15 42.5 ± 4.5 44.7 ± 5.2 47.3 ± 5.3 28.0 ± 5.8 37.4 44.1 43.8
Gireke (NSW) 15 4.7 ± 1.3 4.4 ± 2.0 3.3 ± 1.2 1.5 ± 0.7 64.6 25.9 49.4
Tallangatta Valley 
(Vic) 15 75.5 ± 14.9 48.5 ± 7.0 76.4 ± 13.9 21.1 ± 3.5 56.4 63.2 56.9
Maffra A (Vic) 14 16.6 ± 5.5 14.4 ± 5.6 10.3 ± 6.4 5.2 ± 4.5 63.7 14.1 41.6
*Maffra B (Vic) 15 na na 14.4 ± 5.6 18.7 ± 5.7 na 6.1 na
% positive % positive
Table 3
FEC, coproantigen levels and ﬂuke numbers from slaughter trials. Faecal egg count
(eggs/10 g faeces), coproantigen levels and number of ﬂuke recovered from TCBZ-
treated cattle obtained from animals on properties identiﬁed as having TCBZ resistant
F. hepatica populations (N = Numbugga, TV = Tallangatta Valley, G = Gireke). Copro-
antigen levels are expressed as a percentage of the positive control antigen (%
positive) provided with the BIOX coproantigen kit (cut-off or negativity = 1.3%).
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which compares post-treatment arithmetic means of treated and
control groups (Coles et al., 1992); Method 2 uses means of indi-
vidual animal pre- and post-treatment counts to derive individual
FECR reductions (Pook et al., 2002); Method 3 uses changes in the
untreated control group means to correct for changes in FECR be-
tween collection dates using arithmetic means (Dash et al., 1988).Animal FEC % Positive Fluke #
N 1 26 15.3 20
N 2 19 5.6 23
N 3 12 13.5 24
TV 1 7 22.7 20
TV 2 27 34.1 31
G 1 30 15.0 242.4. Slaughter trials
On three of the properties where TCBZ resistance was identiﬁed
based on FECR and CR, conﬁrmation was sought through treatment
and slaughter trials. The animals chosen for slaughter were from
the same herds but were not subjects of the original ﬁeld trials.
Three cows positive for coproantigen were purchased from the
Numbugga property, one from the Gireke property and two from
the Tallangatta Valley property. The animals were transported to
CSU and kept on dryland pasture. The Numbugga cattle were
treated orally with TCBZ at 12 mg/kg body weight (Fasinex 240,
Novartis) on the property of origin and then slaughtered 34 days
post-treatment not the recommended 21 days, due to a delay in
ﬁnalising purchase of the cattle from the farmer. The animals from
the Gireke and Tallangatta Valley properties were treated orally
with TCBZ at 12 mg/kg (Flukare C, Virbac Animal Health) at CSU
and slaughtered 21 days later. The livers and gall bladders were
collected for dissection and ﬂuke recovery as described (Brockwell
et al., 2013). Faeces were also analysed for egg count and coproan-
tigen levels at the time of slaughter.3. Results
3.1. On farm resistance testing
The properties had been selected on the basis of earlier positive
FEC for F. hepatica. Positive egg counts and coproantigen levels
were detected on all properties. There was considerable variation
in values within a property reﬂected in a relatively high coefﬁcient
of variation and the overdispersed nature of natural ﬂuke infec-
tions. The data for FEC and FECR are presented in Table 1 and data
for coproantigen levels and CR are shown in Table 2. Resistance, or
TCBZ treatment failure, is deﬁned as less than 90% reduction in FEC
or coproantigen. Resistance was found on the Maffra dairy prop-
erty using both methods (CRT and FECRT) and on 4/7 beef proper-ties (Nimmitabel, Numbugga, Gireke, Tallangatta Valley) using CRT
and on 3/6 beef properties (Numbugga, Gireke, Tallangatta Valley)
using FECRT. Faecal egg count data was unavailable for one beef
property. Both methods detected resistance but the percentage
reductions varied for FEC and coproantigen on all properties.
3.2. Recovery of ﬂukes in slaughter trials
Live adult ﬂukes were recovered from all 6 animals following
TCBZ treatment demonstrating that a TCBZ dose that is known to
remove susceptible ﬂuke was ineffective on animals from all 3
properties that were tested (Numbugga, Gireke and Tallangatta
Valley). These results also eliminated the possibility that positive
FEC and coproantigen measures were false positives. Table 3 shows
the number of ﬂuke recovered, FEC and coproantigen level on the
day of slaughter. The correlation between FEC and ﬂuke number
was R2 = 0.1801 and for coproantigen R2 = 0.3542. Although the
sample size is small, the results conﬁrm the TCBZ resistant status
of the ﬂuke in these 6 cattle derived from the herds on the Numb-
ugga, Gireke and Tallangatta Valley properties.4. Discussion
4.1. Optimisation of the coproantigen ELISA test
The coproantigen protocols used here were based on our previ-
ous evaluation of the BIOX coproantigen ELISA in a trial using an
artiﬁcial infection in cattle (Brockwell et al., 2013). Analysis of
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2011a) and cattle (Brockwell et al., 2013) to not affect coproantigen
quantitation. Several studies using the BIOX coproantigen kit have
adhered to the manufacturer’s instructions using a cut-off for pos-
itivity of 0.15 OD or equivalent when expressed as a percentage of
the supplied control antigen (Martínez-Valladares et al., 2010;
Flanagan et al., 2011b; Bernardo et al., 2012; Novobilsky et al.,
2012; Robles-Pérez et al., 2013). However, Novobilsky et al.
(2012) expressed concerns as to the high rate of false negatives
when using the BIOX kit’s recommended negative cut-off point
for positivity and called for further veriﬁcation of the ELISA’s sen-
sitivity. The revised cut off used in our present study was based on
earlier studies in cattle (Brockwell et al., 2013), which improved
the test’s sensitivity by removing false negatives. In a recent eval-
uation of the coproantigen ELISA kit for routine use, Palmer et al.
(2013) also established lower custom cut-offs to improve
sensitivity.
This is the ﬁrst study to evaluate the BIOX coproantigen test for
assessing F. hepatica infection status in ﬁeld trials in naturally in-
fected animals maintained on pasture in commercial settings.
The test proved to be robust in measuring infection and also deliv-
ers advantages in allowing the delayed analysis of fecal samples
through freezing which provides efﬁciencies in cost of analysis
by allowing batching of samples (Brockwell et al., 2013). The test
reﬂects parasite burdens and provides the opportunity to estimate
intensity of infection (Mezo et al., 2004; Brockwell et al., 2013) and
thus an assessment whether the burdens exceed the threshold for
production losses in cattle of about 30–40 ﬂukes (Hope-Cawdery
et al., 1977; Vercruysse and Claerebout, 2001). The ELISA platform
is universal in diagnostic laboratories and so this test is widely
applicable. On the other hand, microscopy skills required for egg
counting and identiﬁcation require specialist skills.
4.2. Evaluation of TCBZ resistance in cattle
Our study investigated suspected cases of reduced efﬁcacy of
TCBZ on 8 cattle properties in South-eastern Australia. Our studies
conﬁrm the widespread existence of TCBZ resistance in cattle herds
using FECRT, CRT and through the recovery of live adult ﬂukes
post-TCBZ treatment from three independent cattle herds. Resis-
tance (<90% reduction in FECRT or CRT) was detected on 4/7 prop-
erties using FECRT and 5/8 properties using CRT. It is possible that
TCBZ resistance has arisen independently on these farms; however,
given the climate and management systems in the southern region
of Australia, and the fact that sheep and cattle co-graze and can
share F. hepatica, the presence of resistance in cattle is not surpris-
ing given the occurrence of resistant parasites in sheep (Overend
and Bowen, 1995). In support of this, live ﬂuke were also recovered
post-treatment with TCBZ from sheep on both the Tallangatta Val-
ley and Gireke properties (Brockwell et al., unpublished data).
Movement of stock between farms can contribute to migration of
resistant ﬂuke and cannot be eliminated here as a means of spread.
Genetic tests may help describe the origins of the ﬂuke populations
and this is the subject of further study (Elliott et al., 2013). The lack
of resistance in the northern cluster of beef properties may reﬂect
different genetic backgrounds in ﬂuke populations or variation in
selection pressures (Sangster and Dobson, 2002). For example,
the lack of sheep in this environment may be signiﬁcant if resistant
ﬂukes develop in sheep and are shared with cattle. However, cases
of resistance in ﬂuke in cattle such as those reported in the Neth-
erlands (Moll et al., 2000), or on the dairy cattle in the present
study, suggest that direct selection has occurred in ﬂuke popula-
tions in cattle. Further testing is required to establish the dynamics
of selection.
Failure of anthelmintic treatment may be due to factors other
than resistance; examples are: poor drug delivery through faultydrench guns; under-dosing of animals due to inaccurate weighing
and dose calculation; poor storage and handling of drenches and
therefore reduced drug quality; or reduced drug metabolism in
the host animal due to earlier liver damage. For example, the Leon
isolate was ﬁrst reported to be resistant (Alvarez-Sanchez et al.,
2006) but FECRT and CRT and conﬁrmation at necropsy showed
it to be susceptible (Flanagan et al., 2011b). In the current study,
we followed recommended guidelines for treatment on a number
of properties and the subsequent slaughter study provides strong
evidence of resistance in these ﬂuke populations.
4.3. Evaluation of methods for determining resistance using FECRT and
CRT
There are no standardised tests or guidelines for the determina-
tion of drug resistance in F. hepatica. For nematodes, standardised
methods (Coles et al., 2006) are available but are currently under
review as new approaches are explored. The characteristics of a
suitable test are that the methods are technically achievable, that
the values they generate are repeatable and that they reﬂect para-
site burdens, including burdens present following treatment. Pre-
vious data in artiﬁcially infected cattle using the modiﬁcations
described by Brockwell et al. (2013) and in sheep (Flanagan
et al., 2011a) show that the FEC and coproantigen ELISA have suit-
able characteristics for resistance tests.
The World Association for the Advancement of Veterinary Par-
asitology (WAAVP) 1995 guidelines include guidance on clinical
trials with Fasciola (Wood et al., 1995). They recommend that efﬁ-
cacy should be determined by FEC three weeks after treatment. The
present study followed these guidelines. Three weeks is a long de-
lay, but was justiﬁed to allow ample time for the removal of adult
ﬂuke in large animals following treatment and allow for the clear-
ance of any ﬂuke eggs potentially stored in the gall bladder. It also
allows time for additional immature ﬂukes that survive treatment
to mature to antigen production and elevate coproantigen levels.
Three weeks is also a long delay for a farmer to hold treatment
while waiting for a laboratory result. Flanagan et al. (2011b)
adopted a 14 day post treatment FEC test in sheep and used the
parameter of a positive coproantigen level as an indication for
resistance. In their hands, all but one animal that was infected with
drug-susceptible ﬂukes and treated with TCBZ returned a zero
antigen level by 14 days. In our hands, in artiﬁcially infected cattle,
both ﬂuke FEC and coproantigen levels fell to negative values with-
in 7 days after treatment (Brockwell et al., 2013). Because TCBZ
kills immature ﬂuke the issue of development of immature ﬂuke
to coproantigen producing status is not likely to be a problem.
On the other hand, analysis of FEC and coproantigen at day 7 after
treatment may not be a good protocol for albendazole testing as
noted by Novobilsky et al. (2012). Flanagan and others used a
95% reduction in FECRT to signal resistance. We elected to use a
more conservative 90% reduction in FECRT as the threshold for
resistance as adopted for Australian ﬂukicide efﬁcacy trials (AVP-
MA 2001). A group size of 15 was chosen because it was the upper
limit for nematode testing, is feasible for farmers in the ﬁeld and
would assist in reducing statistical variance.
The merits of various methods of analysis of FECRT have been
debated in the literature. We employed two techniques (FECRT
and CRT) as resistance tests and analysed the data using three
existing methods (Dash et al., 1988; Coles et al., 1992; Pook
et al., 2002). It is clear from Tables 1 and 2 that Method 2 fails to
provide reliable data in our hands for both tests on two properties
(Parrots Nest, Irvington). Method 2 compares pre- and post-treat-
ment levels in the same animal and does not account for changes
in control levels over time (3 weeks). While this is a useful method
for nematode parasites, especially when group numbers are small,
the values obtained in the tests here varied between collection
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the control groups between the pre- and post- treatments samples
varied over 3 fold between properties, ranging from a 36% reduc-
tion (Tallangatta Valley) to a 212% increase (Nimmitabel) as a per-
centage of positive control antigen. We observed a 2–6 fold
variation in coproantigen levels over a consecutive 5 day period
in our previous study and such variation could be due to biological
or day to day variation in antigen release (Brockwell et al., 2013) or
variation in feed availability which may alter faecal volume. The
relatively long 3 week period between pre and post sampling
would also allow more parasites to contribute to test levels espe-
cially in the window up to 8 weeks for FEC and 5 weeks for copro-
antigen analysis. Animals with negative results pre-treatment also
appeared to cause an underestimation of the efﬁcacy when using
Method 2 in the analysis because values can only increase or re-
main the same. The fact that Method 2 scores both tests similarly
for the Parrots Nest and Irvington properties (% reductions of 48.6
and 63.1 vs. 65.5 and 55.2, respectively) indicates that the two
tests reﬂect similar phenomena. This close agreement is a good
measure of equivalence as statistical errors are highest nearer to
50% reduction.
Methods 1 and 3 give similar results on each property for FECRT
and CRT. Method 1 remains favoured because its derivation gener-
ates less statistical error and relies on post treatment results only
so is cheaper for a farmer to apply. Considering the calculations
with Method 1, resistance was detected using both FECRT and
CRT and the agreement between the two reduction tests is excel-
lent. Existing methods including those used here presume a known
distribution of data. Methods that are independent of distribution
are likely to provide more accurate estimates of means and hence %
reduction. Future work will investigate biases in these analyses
and use simulations to optimise test parameters such as study de-
sign and group size.
An additional beneﬁt of comparing control and post-treatment
values is that it is amenable to a cheap ﬁeld test for resistance
using a herd analysis. When monitoring herd health for parasitism
in grazing animals, it is a common practice to pool a number of fae-
cal samples from the group for diagnosis (Eysker and Ploeger,
2000). Experimental evaluation of pooling known faecal samples
from cattle prior to analysis with the coproantigen ELISA demon-
strated that the pooled result is a mean of the values from samples
tested individually (Brockwell et al., 2013). Our recommended pro-
tocol for efﬁcient and affordable ﬁeld testing to identify ﬂuke drug
resistance (and success of treatment) is: (i) Fourteen days after
treatment with the recommended dose by a farmer, faecal samples
are taken from 15 animals and 3 pools of faeces from 5 animals
each are subject to coproantigen testing; (ii) A value above back-
ground in any sample post-treatment gives 95% conﬁdence that
ﬂukes have survived in at least one of the 15 animals tested in
the pooled sample. Coproantigen testing in this context is forgiving
with respect to transport times and the samples can be shipped
frozen (Brockwell et al., 2013).
Martinez-Perez et al. (2012) compared FEC and coproantigen
ELISA, with both a standard and nested faecal PCR assay, report-
ing that the ELISA and both PCR techniques improved the early
diagnosis of ﬂuke infection over FEC. More recently these
researchers compared these three techniques for use in the detec-
tion of ﬂuke drug resistance in sheep (Robles-Pérez et al., 2013),
ﬁnding PCR to be the most sensitive. However the authors used
the coproantigen ELISA kit manufacturer’s recommendations of
an optical density of 0.15 as the cut-off value for positivity. Our
results applying this test in cattle suggests that this OD value is
too high for accuracy in the detection of low ﬂuke burdens and
antigen levels in faeces (Brockwell et al., 2013). Further evalua-
tion of these PCR techniques in the detection of TCBZ resistance
is warranted.4.4. Conclusions
In this study we have demonstrated the presence of TCBZ resis-
tance in F. hepatica in cattle from a range of properties and produc-
tion systems in South-eastern Australia using the FECRT and CRT.
The FECRT has been applied in a similar fashion to investigations
of anthelmintic resistance in nematode parasites and follows the
same analysis. The CRT provides an alternative test and offers sev-
eral advantages: (i) the coproantigen ELISA shows a moderate to
good association with parasite burdens with R2 values ranging
from 0.239 to 0.871 in cattle (Brockwell et al., 2013) to R = 0.889
in lambs (Mezo et al., 2004) and reﬂects the intensity of infection;
(ii) it can evaluate treatment efﬁcacy in the pre-patent infection
stage since the CRT detects infections within 6–8 weeks of infec-
tion in cattle; (iii) coproantigen levels fall to zero well within
14 days of successful treatment, reducing the interval required be-
tween treatment and collection from 21 to 14 days; this testing
interval aligns with recommendations for nematodes (10–14 days)
so it would be possible to test nematode and ﬂuke resistance in
parallel even on the same 30 animals following treatment with a
combination of a nematocide and a ﬂukicide; (iv) the coproantigen
in the samples is stable and withstands freezing and an extended
shelf life, so laboratory scheduling is more ﬂexible; (v) the oppor-
tunity to pool samples and only collect and analyse post-treatment
provides a cheaper option for a farmer for ﬁeld resistance testing;
(vi) the coproantigen test has high speciﬁcity (vii) the results par-
allel the FECRT. We conclude that, provided custom cut-offs are
determined to improve sensitivity, the coproantigen ELISA remains
the simplest quantitative technology for routine detection of ﬂuke
infection in livestock.Acknowledgements
This work forms part of the Linkage project LP0991268 ‘‘Liver
ﬂuke: improving disease control through understanding of parasite
diversity, drug resistance and better diagnosis’’ funded by the Aus-
tralian Research Council in collaboration with Virbac (Australia)
Pty Ltd. This research was also supported by funds from Charles
Sturt University and La Trobe University. We thank the cattle pro-
ducers involved, NSW Livestock Health and Pest Authority (LHPA)
district veterinarians; Ian Lugton, Chris Haylock, Phil Kemsley,
Steve Whittaker; rangers Matt Taylor and Neil Witsed; Victorian
Department of Primary Industries district veterinarian Jeff Cave
and livestock ofﬁcer Matt Bollen; and Richard Shephard from HiCo
Australia Pty Ltd for assistance regarding the dairy property. The
third author (GRA) works for a company that sells ﬂukicides. This
relationship was used to facilitate the research reported here and
there was no inappropriate inﬂuence on the design or conduct of
the research. The other authors disclose no conﬂicts of interest.
This research was conducted with approval by Charles Sturt Uni-
versity’s Animal Care and Ethics Committee.References
Alvarez-Sanchez, M., Mainar-Jaime, R., Perez-Garcia, J., Rojo-Vázquez, F., 2006.
Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in
Spain. Vet. Rec. 159, 424–425.
APVMA Gazette National Registration Authority. 6, 5 June 2001. <http://
www.apvma.gov.au/publications/gazette/2001/06/gazette0106p31.php>.
Bernardo, C., Avelar, B., Ignacchiti, M., Martins, I., Pereira, M., 2012. Kit commercial
de ELISA para a detecção de coproantígenos e exame coproparasitológico em
bovinos com fígados condenados por fasciolose. Ciência Rural 42, 2025–2029.
Boray, J.C., revised by G.W. Hutchinson and S. Love, 2007. Liver ﬂuke disease in
sheep and cattle. Primefact 446, NSW Department of Primary Industries.
Brockwell, Y.M., Spithill, T.W., Anderson, G.R., Grillo, V., Sangster, N.C., 2013.
Comparative kinetics of serological and copro-antigen ELISA and faecal egg
count in cattle experimentally infected with Fasciola hepatica and following
treatment with triclabendazole. Vet. Parasitol. 196, 417–426.
54 Y.M. Brockwell et al. / International Journal for Parasitology: Drugs and Drug Resistance 4 (2014) 48–54Coles, G.C., Bauer, C., Borgsteede, F.H.M., Geerts, S., Klei, T.R., Taylor, M.A., Waller,
P.J., 1992. World Association for the Advancement of Veterinary Parasitology
(W.A.A.V.P.) methods for the detection of anthelmintic resistance in nematodes
of veterinary importance. Vet. Parasitol. 44, 35–44.
Coles, G.C., Jackson, F., Pomroy, W.E., Prichard, R.K., Von Samson-Himmelstjerna, G.,
Silvestre, A., Taylor, M.A., Vercruysse, J., 2006. The detection of anthelmintic
resistance in nematodes of veterinary importance. Vet. Parasitol. 136, 167–185.
Dash, K.M., Hall, E., Barger, I.A., 1988. The role of arithmetic and geometric mean
worm egg counts in faecal egg count reduction tests and in monitoring strategic
drenching programs in sheep. Aust. Vet. J. 65, 66–68.
Elliott, T., Muller, A., Brockwell, Y., Murphy, N., Grillo, V., Toet, H.M., Anderson, G.,
Sangster, N., Spithill, T.W., 2013. Evidence for high genetic diversity of NAD1
and COX1 mitochondrial haplotypes among triclabendazole resistant and
susceptible populations and ﬁeld isolates of Fasciola hepatica (liver ﬂuke) in
Australia. Vet. Parasitol. (in press).
Eysker, M., Ploeger, H.W., 2000. Value of present diagnostic methods for
gastrointestinal nematode infections in ruminants. Parasitology 120 (Suppl.),
S109–S119.
Fairweather, I., 2009. Triclabendazole progress report, 2005–2009: an advancement
of learning? J. Helminthol. 83, 139–150.
Flanagan, A.M., Edgar, H.W.J., Forster, F., Gordon, A., Hanna, R.E.B., McCoy, M.,
Brennan, G.P., Fairweather, I., 2011a. Standardisation of a coproantigen
reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole
in Fasciola hepatica. Vet. Parasitol. 176, 34–42.
Flanagan, A.M., Edgar, H.W.J., Gordon, A., Hanna, R.E.B., Brennan, G.P., Fairweather,
I., 2011b. Comparison of two assays, a faecal egg count reduction test (FECRT)
and a coproantigen reduction test (CRT), for the diagnosis of resistance to
triclabendazole in Fasciola hepatica in sheep. Vet. Parasitol. 176, 170–176.
Gaasenbeek, C.P.H., Moll, L., Cornelissen, J.B.W.J., Vellema, P., Borgsteede, F.H.M.,
2001. An experimental study on triclabendazole resistance of Fasciola hepatica
in sheep. Vet. Parasitol. 95, 37–43.
Gordon, D.K., Zadoks, R.N., Stevenson, H., Sargison, N.D., Skuce, P.J., 2012. On farm
evaluation of the coproantigen ELISA and coproantigen reduction test in
Scottish sheep naturally infected with Fasciola hepatica. Vet. Parasitol. 187, 436–
444.
Hope-Cawdery, M.J., Strickland, K.L., Conway, A., Crowe, P.J., 1977. Production
effects of liver ﬂuke in cattle I. The effects of infection on live weight gain, feed
intake and food conversion efﬁciency in beef cattle. Br. Vet. J. 133, 145–159.
Kajugu, P.E., Hanna, R.E., Edgar, H.W., Forster, F.I., Malone, F.E., Brennan, G.P.,
Fairweather, I., 2012. Speciﬁcity of a coproantigen ELISA test for fasciolosis: lack
of cross-reactivity with Paramphistomum cervi and Taenia hydatigena. Vet. Rec.
171, 502.
Martinez-Perez, J.M., Robles-Perez, D., Rojo-Vazquez, F.A., Martinez-Valladares, M.,
2012. Comparison of three different techniques to diagnose Fasciola hepatica
infection in experimentally and naturally infected sheep. Vet. Parasitol. 190,
80–86.
Martínez-Valladares, M., del Rosario Famularo, M., Fernández-Pato, N., Castañón-
Ordóñez, L., Cordero-Pérez, C., Rojo-Vázquez, F.A., 2010. Efﬁcacy of nitroxynil
against Fasciola hepatica resistant to triclabendazole in a naturally infected
sheep ﬂock. Parasitol. Res. 107, 1205–1211.
Mezo, M., Gonzalez-Warleta, M., Carro, C., Ubeira, F.M., 2004. An ultrasensitive
capture ELISA for detection of Fasciola hepatica coproantigens in sheep and
cattle using a new monoclonal antibody (MM3). J. Parasitol. 90, 845–852.Mitchell, G.B., Maris, L., Bonniwell, M.A., 1998. Triclabendazole-resistant liver ﬂuke
in Scottish sheep. Vet. Rec. 143, 399.
MLA, 2005. The cattle parasite atlas: A regional guide to cattle parasite control in
Australia. Meat & Livestock Australia. <http://www.mla.com.au/Livestock-
production/Animal-health-welfare-and-biosecurity/Parasites/Cattle-parasite-
atlas>.
Moll, L., Gaasenbeek, C.P.H., Vellema, P., Borgsteede, F.H.M., 2000. Resistance of
Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands.
Vet. Parasitol. 91, 153–158.
Mooney, L., Good, B., Hanrahan, J.P., Mulcahy, G., de Waal, T., 2009. The comparative
efﬁcacy of four anthelmintics against a natural acquired Fasciola hepatica
infection in hill sheep ﬂock in the west of Ireland. Vet. Parasitol. 164, 201–205.
Novobilsky, A., Averpil, H.B., Hoglund, J., 2012. The ﬁeld evaluation of albendazole
and triclabendazole efﬁcacy against Fasciola hepatica by coproantigen ELISA in
naturally infected sheep. Vet. Parasitol. 190, 272–276.
Olaechea, F., Lovera, V., Larroza, M., Raffo, F., Cabrera, R., 2011. Resistance of Fasciola
hepatica against triclabendazole in cattle in Patagonia (Argentina). Vet.
Parasitol. 178, 364–366.
Ortiz, P., Scarcella, S., Cerna, C., Rosales, C., Cabrera, M., Guzmán, M., Lamenza, P.,
Solana, H., 2013. Resistance of Fasciola hepatica against triclabendazole in cattle
in Cajamarca (Peru): a clinical trial and an in vivo efﬁcacy test in sheep. Vet.
Parasitol. 195, 118–121.
Overend, D.J., Bowen, F.L., 1995. Resistance of Fasciola hepatica to triclabendazole.
Austr. Vet. J. 72, 275–276.
Palmer, D.G., Lyon, J., Palmer, M., Forshaw, D., 2013. Diagnostic sensitivity and
speciﬁcity of a F. hepatica copro-antigen ELISA and its use for maintaining
freedom of liver ﬂuke infection in Western Australia. In: 24th International
Conference of the World Association for the Advancement of Veterinary
Parasitology, Perth, August.
Pook, J.F., Power, M.L., Sangster, N.C., Hodgson, J.L., Hodgson, D.R., 2002. Evaluation
of tests for anthelmintic resistance in cyathostomes. Vet. Parasitol. 106, 331–
343.
Robles-Pérez, D., Martínez-Pérez, J.M., Rojo-Vázquez, F.A., Martínez-Valladares, M.,
2013. The diagnosis of fasciolosis in feces of sheep by means of a PCR and its
application in the detection of anthelmintic resistance in sheep ﬂocks naturally
infected. Vet. Parasitol. 197, 277–282.
Sangster, N.C., Dobson, R.J., 2002. Anthelmintic resistance. In: Lee, D.L. (Ed.), The
Biology of Nematodes. Taylor and Francis, London and New York, pp. 531–567.
Sargison, N.D., Scott, P.R., 2011. Diagnosis and economic consequences of
triclabendazole resistance in Fasciola hepatica in a sheep ﬂock in south-east
Scotland. Vet. Rec. 168, 159–164.
Thomas, I., Coles, G.C., Duffus, K., 2000. Triclabendazole-resistant Fasciola hepatica in
southwest Wales. Vet. Rec. 146, 200.
Vercruysse, J., Claerebout, E., 2001. Treatment vs. non-treatment of helminth
infections in cattle: deﬁning the threshold. Vet. Parasitol. 98, 195–214.
Winkelhagen, A.J.S., Mank, T., de Vries, P.J., Soetekouw, R., 2012. Apparent
triclabendazole-resistant human Fasciola hepatica infection, the Netherlands.
Emerg. Infect. Dis. 18, 1028–1029.
Wood, I.B., Amaral, N.K., Bairden, K., Duncan, J.L., Kassai, T., Malone Jr., J.B.,
Pankavich, J.A., Reinecke, R.K., Slocombe, O., Taylor, S.M., Vercruysse, J., 1995.
World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.)
second edition of guidelines for evaluating the efﬁcacy of anthelmintics in
ruminants (bovine, ovine, caprine). Vet. Parasitol. 58, 181–213.
